Publications by authors named "J Sokolar"
Article Synopsis
- - The study examined how various immunosuppressive therapies affect immune responses in patients with autoimmune inflammatory rheumatic diseases (AIRDs) after receiving two doses of an mRNA-based COVID-19 vaccine.
- - Among 92 patients, the first vaccination showed only 37.8% developed neutralizing antibodies, while 94.5% achieved this after the second dose; those on IL-17 inhibitors had the highest antibody levels.
- - Despite differences in treatments, T-cell immunity was similar across therapy types, indicating a generally positive response to vaccination, particularly following the second dose, especially for patients on IL-17 inhibitors.
The severe acute respiratory coronavirus type 2 (SARS-CoV-2) pandemic is keeping most countries of the world in suspense. In Germany the prevalence of SARS-CoV‑2 infections is under 2% but for weeks the numbers in Germany have also been increasing. The care in rheumatology was temporarily impaired by the first wave of the pandemic.
View Article and Find Full Text PDF